首页 > 最新文献

Journal of Natural Medicines最新文献

英文 中文
Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro 参久草散对体外 SARS-CoV-2 木瓜蛋白酶样蛋白酶活性的抑制作用
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-21 DOI: 10.1007/s11418-024-01788-0
Yuka Kiba, Takashi Tanikawa, Tsuyoshi Hayashi, Takami Yokogawa, Aiko Sano, Ryuichiro Suzuki, Masashi Kitamura

Papain-like protease (PLpro) enzyme plays a vital role in viral replication as it breaks down polyproteins and disrupts the host's immune response. There are few reports on Kampo formulas that focus on PLpro activity. In this study, we evaluated the inhibitory effects of senkyuchachosan, a traditional Japanese medicine, on PLpro of SARS-CoV-2, the virus responsible for causing COVID-19. We purified the PLpro enzyme and conducted in vitro enzymatic assays using specific substrates. Among the nine crude drugs present in senkyuchachosan, four (Cyperi Rhizoma, Schizonepetae Spica, Menthae Herba, and Camelliae sinensis Folium [CsF]) strongly inhibited PLpro activity. CsF, derived from Camellia sinensis (green tea), contains polyphenols, including catechins and tannins. To confirm that the PLpro inhibitory effects of senkyuchachosan predominantly stem from tannins, the tannins were removed from the decoction using polyvinylpolypyrrolidone (PVPP). The inhibitory effect of senkyuchachosan on PLpro activity was reduced by the removal of PVPP. In addition, the tannin fraction obtained from the CsF extracts showed significant PLpro inhibitory effects. These findings lay the groundwork for the potential development of therapeutic agents that target SARS-CoV-2 infection by intervening in proteolytic cleavage of the virus.

木瓜蛋白酶(Papain-like protease,PLpro)在病毒复制过程中起着至关重要的作用,因为它能分解多聚蛋白,破坏宿主的免疫反应。很少有关于康普配方的报告关注木瓜蛋白酶的活性。在本研究中,我们评估了日本传统药物仙草散对 SARS-CoV-2(引起 COVID-19 的病毒)的 PLpro 的抑制作用。我们纯化了 PLpro 酶,并使用特定底物进行了体外酶学试验。在仙草散中的九种粗制药物中,有四种(香附、五味子、薄荷和山茶叶 [CsF])能强烈抑制 PLpro 的活性。CsF 提取自山茶(绿茶),含有儿茶素和单宁等多酚类物质。为了证实仙草茶散对 PLpro 的抑制作用主要来自单宁酸,我们使用聚乙烯基吡咯烷酮(PVPP)去除煎煮液中的单宁酸。去除 PVPP 后,仙草茶散对 PLpro 活性的抑制作用减弱。此外,从 CsF 提取物中获得的单宁酸部分对 PLpro 有显著的抑制作用。这些发现为通过干预病毒的蛋白水解作用来开发针对 SARS-CoV-2 感染的治疗药物奠定了基础。
{"title":"Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro","authors":"Yuka Kiba,&nbsp;Takashi Tanikawa,&nbsp;Tsuyoshi Hayashi,&nbsp;Takami Yokogawa,&nbsp;Aiko Sano,&nbsp;Ryuichiro Suzuki,&nbsp;Masashi Kitamura","doi":"10.1007/s11418-024-01788-0","DOIUrl":"10.1007/s11418-024-01788-0","url":null,"abstract":"<p>Papain-like protease (PLpro) enzyme plays a vital role in viral replication as it breaks down polyproteins and disrupts the host's immune response. There are few reports on Kampo formulas that focus on PLpro activity. In this study, we evaluated the inhibitory effects of senkyuchachosan, a traditional Japanese medicine, on PLpro of SARS-CoV-2, the virus responsible for causing COVID-19. We purified the PLpro enzyme and conducted in vitro enzymatic assays using specific substrates. Among the nine crude drugs present in senkyuchachosan, four (Cyperi Rhizoma, Schizonepetae Spica, Menthae Herba, and Camelliae sinensis Folium [CsF]) strongly inhibited PLpro activity. CsF, derived from <i>Camellia sinensis</i> (green tea), contains polyphenols, including catechins and tannins. To confirm that the PLpro inhibitory effects of senkyuchachosan predominantly stem from tannins, the tannins were removed from the decoction using polyvinylpolypyrrolidone (PVPP). The inhibitory effect of senkyuchachosan on PLpro activity was reduced by the removal of PVPP. In addition, the tannin fraction obtained from the CsF extracts showed significant PLpro inhibitory effects. These findings lay the groundwork for the potential development of therapeutic agents that target SARS-CoV-2 infection by intervening in proteolytic cleavage of the virus.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"784 - 791"},"PeriodicalIF":2.5,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent trends in ginseng research 人参研究的最新趋势。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-21 DOI: 10.1007/s11418-024-01792-4
Honoka Ito, Michiho Ito

Ginseng, the dried root of Panax ginseng, contains ginsenosides and has long been used in Korea, China, and Japan to treat various symptoms. Many studies on the utility of ginseng have been conducted and in this paper we investigate recent trends in ginseng research. P. ginseng studies were collected from scientific databases (PubMed, Web of Science, and SciFindern) using the keywords “Panax ginseng C.A. Meyer”, “ginsenosides”, “genetic diversity”, “biosynthesis”, “cultivation”, and “pharmacology”. We identified 1208 studies up to and including September 2023: 549 studies on pharmacology, 262 studies on chemical components, 131 studies on molecular biology, 58 studies on cultivation, 71 studies on tissue culture, 28 studies on clinical trials, 123 reviews, and 49 studies in other fields. Many researchers focused on the characteristic ginseng component ginsenoside to elucidate the mechanism of ginseng’s pharmacological action, the relationship between component patterns and cultivation areas and conditions, and gene expression.

Graphical abstract

人参是三七的干燥根茎,含有人参皂苷,长期以来一直被韩国、中国和日本用于治疗各种症状。有关人参功效的研究很多,本文将探讨人参研究的最新趋势。我们以 "Panax ginseng C.A. Meyer"、"ginsenosides"、"genetic diversity"、"biosynthesis"、"cultation "和 "pharmacology "为关键词,从科学数据库(PubMed、Web of Science和SciFindern)中收集了有关人参的研究。截至 2023 年 9 月(含 2023 年 9 月),我们共检索到 1208 项研究:其中药理学研究 549 项,化学成分研究 262 项,分子生物学研究 131 项,栽培研究 58 项,组织培养研究 71 项,临床试验研究 28 项,综述研究 123 项,其他领域研究 49 项。许多研究人员关注人参的特征成分人参皂苷,以阐明人参的药理作用机制、成分模式与栽培地区和条件的关系以及基因表达。
{"title":"Recent trends in ginseng research","authors":"Honoka Ito,&nbsp;Michiho Ito","doi":"10.1007/s11418-024-01792-4","DOIUrl":"10.1007/s11418-024-01792-4","url":null,"abstract":"<div><p>Ginseng, the dried root of <i>Panax ginseng</i>, contains ginsenosides and has long been used in Korea, China, and Japan to treat various symptoms. Many studies on the utility of ginseng have been conducted and in this paper we investigate recent trends in ginseng research. <i>P. ginseng</i> studies were collected from scientific databases (PubMed, Web of Science, and SciFinder<sup>n</sup>) using the keywords “<i>Panax ginseng</i> C.A. Meyer”, “ginsenosides”, “genetic diversity”, “biosynthesis”, “cultivation”, and “pharmacology”. We identified 1208 studies up to and including September 2023: 549 studies on pharmacology, 262 studies on chemical components, 131 studies on molecular biology, 58 studies on cultivation, 71 studies on tissue culture, 28 studies on clinical trials, 123 reviews, and 49 studies in other fields. Many researchers focused on the characteristic ginseng component ginsenoside to elucidate the mechanism of ginseng’s pharmacological action, the relationship between component patterns and cultivation areas and conditions, and gene expression.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"455 - 466"},"PeriodicalIF":2.5,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photoreaction products of extract from the fruiting bodies of Polyozellus multiplex 多子藻子实体提取物的光反应产物。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-21 DOI: 10.1007/s11418-024-01790-6
Hayato Otsuka, Keiyo Nakai, Emi Shimizu, Takamasa Yamaguchi, Mitsuhisa Yamano, Hiroaki Sasaki, Kiyotaka Koyama, Kaoru Kinoshita

Photochemical reactions are powerful tools for synthesizing organic molecules. The input of energy provided by light offers a means to produce strained and unique molecules that cannot be assembled using thermal protocols, allowing for the production of immense molecular complexity in a single chemical step. Furthermore, unlike thermal reactions, photochemical reactions do not require active reagents such as acids, bases, metals, or enzymes. Photochemical reactions play a central role in green chemistry. This article reports the isolation and structure determination of four new compounds (14) from the photoreaction products of the Polyozellus multiplex MeOH ext. The structures of the new compounds were elucidated using MS, IR, comprehensive NMR measurements and microED. The four compounds were formed by deacetylation of polyozellin, the main secondary metabolite of P. multiplex, and addition of singlet oxygen generated by sunlight. To develop drugs for treating Alzheimer’s disease (AD) on the basis of the amyloid cascade hypothesis, the compounds (14) obtained by photoreaction were evaluated for BACE1 inhibitory activity. The hydrolysates (5 and 6) of polyozellin, the main secondary metabolites of P. multiplex, were also evaluated. The photoreaction products (3 and 4) and hydrolysates (5 and 6) of polyozellin showed BACE1 inhibitory activity (IC50: 2.2, 16.4, 23.3, and 5.3 μM, respectively).

Graphical abstract

光化学反应是合成有机分子的强大工具。光能提供的能量可以产生热反应无法合成的独特分子,从而在单一化学步骤中产生复杂的分子。此外,与热反应不同,光化学反应不需要酸、碱、金属或酶等活性试剂。光化学反应在绿色化学中发挥着核心作用。本文报告了从 Polyozellus multiplex MeOH ext 的光反应产物中分离和测定四种新化合物(1-4)的结构。这四种化合物是由多孔菌的主要次级代谢产物多孔菌素脱乙酰基并加入阳光产生的单线态氧而形成的。为了在淀粉样蛋白级联假说的基础上开发治疗阿尔茨海默病(AD)的药物,对通过光反应获得的化合物(1-4)进行了 BACE1 抑制活性评估。此外,还评估了多浆果藻的主要次级代谢产物多浆果藻素的水解物(5 和 6)。光反应产物(3 和 4)和多浆菌素的水解产物(5 和 6)显示出 BACE1 抑制活性(IC50 分别为 2.2、16.4、23.3 和 5.3 μM)。
{"title":"Photoreaction products of extract from the fruiting bodies of Polyozellus multiplex","authors":"Hayato Otsuka,&nbsp;Keiyo Nakai,&nbsp;Emi Shimizu,&nbsp;Takamasa Yamaguchi,&nbsp;Mitsuhisa Yamano,&nbsp;Hiroaki Sasaki,&nbsp;Kiyotaka Koyama,&nbsp;Kaoru Kinoshita","doi":"10.1007/s11418-024-01790-6","DOIUrl":"10.1007/s11418-024-01790-6","url":null,"abstract":"<div><p>Photochemical reactions are powerful tools for synthesizing organic molecules. The input of energy provided by light offers a means to produce strained and unique molecules that cannot be assembled using thermal protocols, allowing for the production of immense molecular complexity in a single chemical step. Furthermore, unlike thermal reactions, photochemical reactions do not require active reagents such as acids, bases, metals, or enzymes. Photochemical reactions play a central role in green chemistry. This article reports the isolation and structure determination of four new compounds (<b>1</b>–<b>4</b>) from the photoreaction products of the <i>Polyozellus multiplex</i> MeOH ext. The structures of the new compounds were elucidated using MS, IR, comprehensive NMR measurements and microED. The four compounds were formed by deacetylation of polyozellin, the main secondary metabolite of <i>P. multiplex</i>, and addition of singlet oxygen generated by sunlight. To develop drugs for treating Alzheimer’s disease (AD) on the basis of the amyloid cascade hypothesis, the compounds (<b>1</b>–<b>4</b>) obtained by photoreaction were evaluated for BACE1 inhibitory activity. The hydrolysates (<b>5</b> and <b>6</b>) of polyozellin, the main secondary metabolites of <i>P. multiplex</i>, were also evaluated. The photoreaction products (<b>3</b> and <b>4</b>) and hydrolysates (<b>5</b> and <b>6</b>) of polyozellin showed BACE1 inhibitory activity (IC<sub>50</sub>: 2.2, 16.4, 23.3, and 5.3 μM, respectively).</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"547 - 557"},"PeriodicalIF":2.5,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140178978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultant compound from sublimation test for Gentianae Radix in Japanese Pharmacopoeia was 5-(hydroxymethyl)furfural 日本药典》中龙胆草升华试验的结果化合物为 5-(羟甲基)糠醛
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-19 DOI: 10.1007/s11418-024-01802-5
Atsushi Tsuge, Yuto Goto, Sayaka Masada, Michiho Ito

Gentianae Radix, an herbal medicine, has been used as a gastrointestinal drug in Japan. In the Japanese Pharmacopoeia 18th Revision, the sublimation test is specified as an identification test for Gentianae Radix. The compound obtained in this sublimation test was believed to be gentisin, a xanthone family compound. However, the compound we identified using liquid chromatography-high-resolution mass spectrometry (LC-HRMS) and 1H- and 13C-NMR was 5-(hydroxymethyl)furfural (5-HMF). The same compound was found to be a sublimate of Gentianae Scabrae Radix and Gentianae Macrophyllae Radix, belonging to the same genus as Gentianae Radix. These results indicate the necessity to revise the identification test for Gentianae Radix to a more unique method.

Graphical abstract

龙胆草是一种草药,在日本一直被用作胃肠道药物。在《日本药典》第 18 版中,升华试验被规定为龙胆草的鉴定试验。在升华试验中获得的化合物被认为是龙胆素,一种黄酮类化合物。然而,我们使用液相色谱-高分辨质谱法(LC-HRMS)以及 1H- 和 13C-NMR 鉴定出的化合物是 5-(羟甲基)糠醛(5-HMF)。该化合物是龙胆草(Gentianae Scabrae Radix)和龙胆草(Gentianae Macrophyllae Radix)的升华产物,与龙胆草同属。这些结果表明,有必要将龙胆草的鉴定试验修改为一种更独特的方法。
{"title":"Resultant compound from sublimation test for Gentianae Radix in Japanese Pharmacopoeia was 5-(hydroxymethyl)furfural","authors":"Atsushi Tsuge,&nbsp;Yuto Goto,&nbsp;Sayaka Masada,&nbsp;Michiho Ito","doi":"10.1007/s11418-024-01802-5","DOIUrl":"10.1007/s11418-024-01802-5","url":null,"abstract":"<div><p>Gentianae Radix, an herbal medicine, has been used as a gastrointestinal drug in Japan. In the Japanese Pharmacopoeia 18th Revision, the sublimation test is specified as an identification test for Gentianae Radix. The compound obtained in this sublimation test was believed to be gentisin, a xanthone family compound. However, the compound we identified using liquid chromatography-high-resolution mass spectrometry (LC-HRMS) and <sup>1</sup>H- and <sup>13</sup>C-NMR was 5-(hydroxymethyl)furfural (5-HMF). The same compound was found to be a sublimate of Gentianae Scabrae Radix and Gentianae Macrophyllae Radix, belonging to the same genus as Gentianae Radix. These results indicate the necessity to revise the identification test for Gentianae Radix to a more unique method.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"799 - 802"},"PeriodicalIF":2.5,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140168651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse 万年青对非酒精性脂肪性肝炎模型小鼠肝脏脂肪变性/纤维化的保护作用
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-18 DOI: 10.1007/s11418-024-01786-2
Kyohei Takano, Marisa Kaneda, Yayoi Aoki, Nina Fujita, Shigeki Chiba, Seiwa Michihara, Li-Kun Han, Ryuji Takahashi

Non-alcoholic steatohepatitis (NASH) is a progressive fibrotic form of non-alcoholic fatty liver disease. Liver fibrosis leads to liver cancer and cirrhosis, and drug therapy for NASH remains lacking. Ninjin’yoeito (NYT) has shown antifibrotic effects in a model of liver fibrosis without steatosis but has not been studied for NASH. Therefore, we evaluated the efficacy of NYT in mice fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) as a NASH model. Compared with the normal diet group, mice fed CDAHFD showed decreased body weight and increased white adipose tissue, liver weight, and triglyceride content in the liver. Furthermore, a substantial increase in the hepatic concentration of hydroxyproline, expression of α-smooth muscle actin (α-SMA), and transforming growth factor-β was observed in CDAHFD-fed mice. Masson’s trichrome and Picro-Sirius red staining revealed a remarkable increase in collagen fiber compared with the normal diet group. Compared with mice that received CDAHFD alone, those supplemented with NYT exhibited reduced hepatic triglyceride and hydroxyproline levels and α-SMA expression. Additionally, compared with the group fed CDAHFD alone, the stained liver tissues of NYT-treated mice exhibited a reduction in Masson’s trichrome- and Picro-Sirius red-positive areas. Locomotor activity was significantly reduced in the CDAHFD-fed group compared with the normal diet group. In the NYT-treated group, the CDAHFD-induced decrease in locomotor activity was significantly suppressed. The findings indicate that NYT inhibited fatty and fibrotic changes in the livers of NASH mice and alleviated the decrease in locomotor activity. Therefore, NYT may serve as a novel therapeutic approach for NASH.

Graphical abstract

摘要 非酒精性脂肪性肝炎(NASH)是非酒精性脂肪肝的一种进行性纤维化形式。肝纤维化会导致肝癌和肝硬化,但目前仍缺乏治疗非酒精性脂肪性肝炎的药物。Ninjin'yoeito(NYT)在无脂肪变性的肝纤维化模型中显示出抗纤维化作用,但尚未对 NASH 进行研究。因此,我们以胆碱缺乏、L-氨基酸定义的高脂饮食(CDAHFD)作为 NASH 模型,评估了 NYT 对小鼠的疗效。与正常饮食组相比,喂食CDAHFD的小鼠体重下降,白色脂肪组织、肝脏重量和肝脏中甘油三酯含量增加。此外,CDAHFD组小鼠肝脏中的羟脯氨酸浓度、α-平滑肌肌动蛋白(α-SMA)和转化生长因子-β的表达均显著增加。与正常饮食组相比,Masson 三色和 Picro-Sirius 红染色显示胶原纤维显著增加。与仅摄入 CDAHFD 的小鼠相比,补充 NYT 的小鼠肝甘油三酯和羟脯氨酸水平以及 α-SMA 表达均有所降低。此外,与单独喂食 CDAHFD 的小鼠相比,经 NYT 处理的小鼠肝脏组织的马森氏三色染色和比色红阳性区域有所减少。与正常饮食组相比,喂食CDAHFD组小鼠的运动活动明显减少。在NYT处理组中,CDAHFD引起的运动活性下降被明显抑制。研究结果表明,NYT抑制了NASH小鼠肝脏的脂肪和纤维化变化,并缓解了小鼠运动能力的下降。因此,NYT可作为治疗NASH的一种新方法。 图表摘要
{"title":"The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse","authors":"Kyohei Takano,&nbsp;Marisa Kaneda,&nbsp;Yayoi Aoki,&nbsp;Nina Fujita,&nbsp;Shigeki Chiba,&nbsp;Seiwa Michihara,&nbsp;Li-Kun Han,&nbsp;Ryuji Takahashi","doi":"10.1007/s11418-024-01786-2","DOIUrl":"10.1007/s11418-024-01786-2","url":null,"abstract":"<div><p>Non-alcoholic steatohepatitis (NASH) is a progressive fibrotic form of non-alcoholic fatty liver disease. Liver fibrosis leads to liver cancer and cirrhosis, and drug therapy for NASH remains lacking. Ninjin’yoeito (NYT) has shown antifibrotic effects in a model of liver fibrosis without steatosis but has not been studied for NASH. Therefore, we evaluated the efficacy of NYT in mice fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) as a NASH model. Compared with the normal diet group, mice fed CDAHFD showed decreased body weight and increased white adipose tissue, liver weight, and triglyceride content in the liver. Furthermore, a substantial increase in the hepatic concentration of hydroxyproline, expression of α-smooth muscle actin (<i>α-SMA</i>), and transforming growth factor-β was observed in CDAHFD-fed mice. Masson’s trichrome and Picro-Sirius red staining revealed a remarkable increase in collagen fiber compared with the normal diet group. Compared with mice that received CDAHFD alone, those supplemented with NYT exhibited reduced hepatic triglyceride and hydroxyproline levels and <i>α-SMA</i> expression. Additionally, compared with the group fed CDAHFD alone, the stained liver tissues of NYT-treated mice exhibited a reduction in Masson’s trichrome- and Picro-Sirius red-positive areas. Locomotor activity was significantly reduced in the CDAHFD-fed group compared with the normal diet group. In the NYT-treated group, the CDAHFD-induced decrease in locomotor activity was significantly suppressed. The findings indicate that NYT inhibited fatty and fibrotic changes in the livers of NASH mice and alleviated the decrease in locomotor activity. Therefore, NYT may serve as a novel therapeutic approach for NASH.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"514 - 524"},"PeriodicalIF":2.5,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11418-024-01786-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140148546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Four new resin glycosides from Ipomoea muricata seeds: muricatins XIV–XVII 从 Ipomoea muricata 种子中提取的四种新树脂苷:Muricatins XIV-XVII。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-08 DOI: 10.1007/s11418-024-01787-1
Masateru Ono, Daiki Tenmaya, Maki Tarumi, Syouri Satou, Kotone Tsuji, Hirotaka Nishikawa, Shin Yasuda, Hiroyuki Miyashita, Jian-Rong Zhou, Kazumi Yokomizo, Hitoshi Yoshimitsu, Ryota Tsuchihashi, Masafumi Okawa, Junei Kinjo

Ipomoea muricata (L.) Jacq. seeds (Convolvulaceae) are used as a traditional laxative and carminative medicine. Muricatins XIV (1), XV (2), XVI (3), and XVII (4), were isolated from I. muricata seeds as four new resin glycosides, along with seven known compounds, three of which were isolated for the first time as natural products; their structures were determined using MS and NMR spectroscopy. Compounds 14 are macrolactones (jalapins); the sugar moieties of 1, 2, and 4 are partially acylated with 2S-methylbutyric acid, while that of 3 is esterified with 2S-methylbutyric and 2S-methyl-3S-hydroxybutyric acids. In addition, the antiviral activities of the seven compounds obtained in this study, together with five known compounds obtained in our previous study into resin glycosides from I. muricata seeds, were evaluated against herpes simplex virus type 1 (HSV-1); their cytotoxicities against HL-60 human promyelocytic leukemia cells were also investigated. All examined jalapins exhibited similar or slightly weaker anti-HSV-1 activities than acyclovir, the positive control; however, the glycosidic acid of 4 was inactive, while its methyl ester was weakly active. On the other hand, cytotoxicity testing against HL-60 cells showed similar results to those observed during anti-HSV-1 activity testing, with the exception that one jalapin was less active.

Graphical Abstract

Ipomoea muricata (L.) Jacq.种子(旋花科)被用作传统的泻药和催眠药。从 Ipomoea muricata 种子中分离出了 Muricatins XIV (1)、XV (2)、XVI (3) 和 XVII (4),它们是四种新的树脂苷,还有七种已知化合物,其中三种是首次作为天然产物分离出来;它们的结构是用 MS 和 NMR 光谱测定的。化合物 1-4 均为大内酯(jalapins);其中 1、2 和 4 的糖基部分与 2S-甲基丁酸酰化,而 3 的糖基部分与 2S-甲基丁酸和 2S-甲基-3S-羟基丁酸酯化。此外,研究人员还评估了本研究中获得的 7 个化合物,以及我们之前研究 I. muricata 种子树脂苷时获得的 5 个已知化合物的抗病毒活性;同时还研究了它们对 HL-60 人类早幼粒细胞白血病细胞的细胞毒性。与阳性对照阿昔洛韦相比,所有受检的贾拉平类药物都表现出相似或稍弱的抗 HSV-1 活性;不过,4 的糖苷酸没有活性,而其甲酯则活性较弱。另一方面,针对 HL-60 细胞的细胞毒性测试显示出与抗 HSV-1 活性测试中观察到的结果相似的结果,但有一种 jalapin 的活性较低。
{"title":"Four new resin glycosides from Ipomoea muricata seeds: muricatins XIV–XVII","authors":"Masateru Ono,&nbsp;Daiki Tenmaya,&nbsp;Maki Tarumi,&nbsp;Syouri Satou,&nbsp;Kotone Tsuji,&nbsp;Hirotaka Nishikawa,&nbsp;Shin Yasuda,&nbsp;Hiroyuki Miyashita,&nbsp;Jian-Rong Zhou,&nbsp;Kazumi Yokomizo,&nbsp;Hitoshi Yoshimitsu,&nbsp;Ryota Tsuchihashi,&nbsp;Masafumi Okawa,&nbsp;Junei Kinjo","doi":"10.1007/s11418-024-01787-1","DOIUrl":"10.1007/s11418-024-01787-1","url":null,"abstract":"<div><p><i>Ipomoea muricata</i> (L.) Jacq. seeds (Convolvulaceae) are used as a traditional laxative and carminative medicine. Muricatins XIV (<b>1</b>), XV (<b>2</b>), XVI (<b>3</b>), and XVII (<b>4</b>), were isolated from<i> I. muricata</i> seeds as four new resin glycosides, along with seven known compounds, three of which were isolated for the first time as natural products; their structures were determined using MS and NMR spectroscopy. Compounds <b>1</b>–<b>4</b> are macrolactones (jalapins); the sugar moieties of <b>1</b>, <b>2</b>, and <b>4</b> are partially acylated with 2<i>S</i>-methylbutyric acid, while that of <b>3</b> is esterified with 2<i>S</i>-methylbutyric and 2<i>S</i>-methyl-3<i>S</i>-hydroxybutyric acids. In addition, the antiviral activities of the seven compounds obtained in this study, together with five known compounds obtained in our previous study into resin glycosides from <i>I. muricata</i> seeds, were evaluated against herpes simplex virus type 1 (HSV-1); their cytotoxicities against HL-60 human promyelocytic leukemia cells were also investigated. All examined jalapins exhibited similar or slightly weaker anti-HSV-1 activities than acyclovir, the positive control; however, the glycosidic acid of <b>4</b> was inactive, while its methyl ester was weakly active. On the other hand, cytotoxicity testing against HL-60 cells showed similar results to those observed during anti-HSV-1 activity testing, with the exception that one jalapin was less active.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"525 - 536"},"PeriodicalIF":2.5,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protopanaxadiol improves lupus nephritis by regulating the PTX3/MAPK/ERK1/2 pathway 原人参酚通过调节 PTX3/MAPK/ERK1/2 通路改善狼疮肾炎
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-03 DOI: 10.1007/s11418-023-01777-9
Zhenyuan Li, Hailin Gan, Kai Ji, Mingyan Yang, Tao Pan, Xiangting Meng, Teng Liu, Zhixia Wang, Baifang Gong, Ke Liu, Dong Qi, Huaying Fan

Lupus nephritis (LN) is a kidney disease that occurs after systemic lupus erythematosus (SLE) affects the kidneys. Pentraxin 3 (PTX3) is highly expressed in the serum of patients with LN. Renal PTX3 deposition is directly related to clinical symptoms such as proteinuria and inflammation. The excessive proliferation of mesangial cells (MCs) is one of the representative pathological changes in the progression of LN, which is closely related to its pathogenesis. Protopanaxadiol (PPD) is the main component of ginsenoside metabolism and has not been reported in LN. The aim of this study was to investigate the relationship between PTX3 and mesangial cell proliferation and to evaluate the potential role and mechanism of PPD in improving LN. PTX3 is highly expressed in the kidneys of LN patients and LN mice and is positively correlated with renal pathological indicators, including proteinuria and PCNA. The excessive expression of PTX3 facilitated the proliferation of MCs, facilitated the activation of the MAPK/ERK1/2 signaling pathway, and increased the expression of HIF-1α. Further studies showed that PPD can effectively inhibit the abnormal proliferation of MCs with high expression of PTX3 and significantly improve LN symptoms such as proteinuria in MRL/lpr mice. The mechanism may be related to the inhibition of the PTX3/MAPK/ERK1/2 pathway. In this study, both in vitro, in vivo, and clinical sample results show that PTX3 is involved in the regulation of MCs proliferation and the early occurrence of LN. Natural active compound PPD can improve LN by regulating the PTX3/MAPK/ERK1/2 pathway.

Graphical abstract

摘要 狼疮性肾炎(LN)是系统性红斑狼疮(SLE)影响肾脏后出现的一种肾脏疾病。五毒素 3(PTX3)在狼疮肾炎患者的血清中高度表达。肾脏 PTX3 沉积与蛋白尿和炎症等临床症状直接相关。间质细胞(MCs)过度增殖是 LN 进展过程中具有代表性的病理变化之一,与 LN 的发病机制密切相关。原人参皂苷(PPD)是人参皂苷代谢的主要成分,在 LN 中尚未见报道。本研究旨在探讨 PTX3 与间质细胞增殖之间的关系,并评估 PPD 在改善 LN 中的潜在作用和机制。PTX3 在 LN 患者和 LN 小鼠的肾脏中高表达,并与蛋白尿和 PCNA 等肾脏病理指标呈正相关。PTX3 的过度表达促进了 MCs 的增殖,促进了 MAPK/ERK1/2 信号通路的激活,并增加了 HIF-1α 的表达。进一步的研究表明,PPD能有效抑制PTX3高表达的MCs的异常增殖,明显改善MRL/lpr小鼠的蛋白尿等LN症状。其机制可能与抑制PTX3/MAPK/ERK1/2通路有关。本研究的体外、体内和临床样本结果均表明,PTX3参与了MCs增殖和LN早期发生的调控。天然活性化合物PPD可通过调节PTX3/MAPK/ERK1/2通路改善LN。 图表摘要
{"title":"Protopanaxadiol improves lupus nephritis by regulating the PTX3/MAPK/ERK1/2 pathway","authors":"Zhenyuan Li,&nbsp;Hailin Gan,&nbsp;Kai Ji,&nbsp;Mingyan Yang,&nbsp;Tao Pan,&nbsp;Xiangting Meng,&nbsp;Teng Liu,&nbsp;Zhixia Wang,&nbsp;Baifang Gong,&nbsp;Ke Liu,&nbsp;Dong Qi,&nbsp;Huaying Fan","doi":"10.1007/s11418-023-01777-9","DOIUrl":"10.1007/s11418-023-01777-9","url":null,"abstract":"<div><p>Lupus nephritis (LN) is a kidney disease that occurs after systemic lupus erythematosus (SLE) affects the kidneys. Pentraxin 3 (PTX3) is highly expressed in the serum of patients with LN. Renal PTX3 deposition is directly related to clinical symptoms such as proteinuria and inflammation. The excessive proliferation of mesangial cells (MCs) is one of the representative pathological changes in the progression of LN, which is closely related to its pathogenesis. Protopanaxadiol (PPD) is the main component of ginsenoside metabolism and has not been reported in LN. The aim of this study was to investigate the relationship between PTX3 and mesangial cell proliferation and to evaluate the potential role and mechanism of PPD in improving LN. PTX3 is highly expressed in the kidneys of LN patients and LN mice and is positively correlated with renal pathological indicators, including proteinuria and PCNA. The excessive expression of PTX3 facilitated the proliferation of MCs, facilitated the activation of the MAPK/ERK1/2 signaling pathway, and increased the expression of HIF-1α. Further studies showed that PPD can effectively inhibit the abnormal proliferation of MCs with high expression of PTX3 and significantly improve LN symptoms such as proteinuria in MRL/lpr mice. The mechanism may be related to the inhibition of the PTX3/MAPK/ERK1/2 pathway. In this study, both in vitro, in vivo, and clinical sample results show that PTX3 is involved in the regulation of MCs proliferation and the early occurrence of LN. Natural active compound PPD can improve LN by regulating the PTX3/MAPK/ERK1/2 pathway.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"474 - 487"},"PeriodicalIF":2.5,"publicationDate":"2024-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140019569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cycloartane-type triterpenoids from the leaves of Sandoricum koetjape and their efficacy on α-glucosidase inhibition activity Sandoricum koetjape 叶子中的环木菠萝烷类三萜及其对 α-葡萄糖苷酶抑制活性的功效。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-01 DOI: 10.1007/s11418-023-01778-8
Tai-Xuan-Hoa Hang, Suekanya Jarupinthusophon, Rita Hairani, Van-Kieu Nguyen, Warinthorn Chavasiri

The preliminary α-glucosidase inhibitory activity of the methanol extract of the leaves of Sandoricum koetjape Merr. exhibited promising results. The leaves was extracted with methanol to obtainthe methanol extract that was continuedly partitioned with hexane and ethyl acetate. Those fractions were further purified by various chromatographic techniques. The isolation of the potent fractions furnished two new cycloartane-type triterpenoids (1 and 2) along with ten known compounds (312). Their chemical structures were unambiguously established by interpretation of NMR (1 D & 2 D) and high-resolution electrospray ionization mass spectrometry (HRESIMS) data. Furthermore, the configurations of two new compounds were determined by using NOESY spectrum as well as comparing their NMR data to the reference. These compounds were evaluated against α-glucosidase. All tested compounds revealed potent activity with IC50 value in the range of 2.17–49.2 µM compared to that of acarbose (IC50 100.6 µM). Compound 10 showed the lowest IC50 value. This compound was reported as a mixed-type inhibitor. Compound 3 possessed the second strong activity with an IC50 value of 14.0 μM and was further investigated on kinetic analysis which revealed as a mixed-type inhibitor with Ki and Ki′ values of 59.1 and 155.2 μM, respectively.

Graphical abstract

Sandoricum koetjape Merr.叶片甲醇提取物的初步α-葡萄糖苷酶抑制活性研究结果令人鼓舞。用甲醇萃取叶片,得到甲醇提取物,再用正己烷和乙酸乙酯继续分馏。这些馏分通过各种色谱技术进一步纯化。从有效馏分中分离出两种新的环安坦类三萜类化合物(1 和 2)以及十种已知化合物(3-12)。通过核磁共振(1 D 和 2 D)和高分辨率电喷雾离子化质谱(HRESIMS)数据的解释,这些化合物的化学结构被明确地确定下来。此外,还利用 NOESY 光谱确定了两种新化合物的构型,并将其 NMR 数据与参照物进行了比较。这些化合物针对α-葡萄糖苷酶进行了评估。与阿卡波糖(IC50 100.6 µM)相比,所有测试化合物都显示出强大的活性,其 IC50 值范围为 2.17-49.2 µM。化合物 10 的 IC50 值最低。据报道,该化合物是一种混合型抑制剂。化合物 3 具有第二强的活性,其 IC50 值为 14.0 μM,进一步的动力学分析表明它是一种混合型抑制剂,其 Ki 和 Ki' 值分别为 59.1 μM 和 155.2 μM。
{"title":"Cycloartane-type triterpenoids from the leaves of Sandoricum koetjape and their efficacy on α-glucosidase inhibition activity","authors":"Tai-Xuan-Hoa Hang,&nbsp;Suekanya Jarupinthusophon,&nbsp;Rita Hairani,&nbsp;Van-Kieu Nguyen,&nbsp;Warinthorn Chavasiri","doi":"10.1007/s11418-023-01778-8","DOIUrl":"10.1007/s11418-023-01778-8","url":null,"abstract":"<div><p>The preliminary α-glucosidase inhibitory activity of the methanol extract of the leaves of <i>Sandoricum koetjape</i> Merr. exhibited promising results. The leaves was extracted with methanol to obtain\u0000the methanol extract that was continuedly partitioned with hexane and ethyl acetate. Those fractions were further purified by various chromatographic techniques. The isolation of the potent fractions furnished two new cycloartane-type triterpenoids (<b>1</b> and <b>2</b>) along with ten known compounds (<b>3</b>–<b>12</b>). Their chemical structures were unambiguously established by interpretation of NMR (1 D &amp; 2 D) and high-resolution electrospray ionization mass spectrometry (HRESIMS) data. Furthermore, the configurations of two new compounds were determined by using NOESY spectrum as well as comparing their NMR data to the reference. These compounds were evaluated against α-glucosidase. All tested compounds revealed potent activity with IC<sub>50</sub> value in the range of 2.17–49.2 µM compared to that of acarbose (IC<sub>50</sub> 100.6 µM). Compound <b>10</b> showed the lowest IC<sub>50</sub> value. This compound was reported as a mixed-type inhibitor. Compound <b>3</b> possessed the second strong activity with an IC<sub>50</sub> value of 14.0 μM and was further investigated on kinetic analysis which revealed as a mixed-type inhibitor with K<sub>i</sub> and K<sub>i</sub>′ values of 59.1 and 155.2 μM, respectively.</p><h3>Graphical abstract</h3>\u0000<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"655 - 663"},"PeriodicalIF":2.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11418-023-01778-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140011933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Angelica acutiloba, A. sinensis, and other Chinese medicinal Apiaceae plants by DNA barcoding 通过 DNA 条形码鉴定当归、中华当归和其他中药繖形花科植物。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-01 DOI: 10.1007/s11418-024-01796-0
Motoyasu Minami, Ryusaku Tanaka, Takako Mori, Taichi Fujii, Takashi Tsuchida

Crude drug Angelicae acutilobae radix is one of the most important crude drugs in Japanese traditional medicine and is used mainly for the treatment of gynecological disorders. In the listing in the Japanese Pharmacopoeia XVIII, Angelicae acutilobae radix is defined as the root of Angelica acutiloba (Apiaceae), which has long been produced on an industrial scale in Japan. With the aging of farmers and depopulation of production areas, the domestic supply has recently declined and the majority of the supply is now imported from China. Due to having only slightly different morphological and chemical characteristics for the Apiaceae roots used to produce dried roots for Chinese medicines, the plant species originating the crude drug Apiaceae roots may be incorrectly identified. In particular, Angelicae sinensis radix, which is widely used in China, and Angelicae acutilobae radix are difficult to accurately identify by morphology and chemical profiles. Thus, in order to differentiate among Angelicae acutilobae radix and other radixes originated from Chinese medicinal Apiaceae plants, we established DNA markers. Using DNA sequences for the chloroplast psbA–trnH intergenic spacer and nuclear internal transcribed spacer regions, Angelicae acutilobae radix and other Chinese Apiaceae roots, including Angelicae sinensis radix, can be definitively identified.

粗制药物当归(Angelicae acutilobae radix)是日本传统医学中最重要的粗制药物之一,主要用于治疗妇科疾病。在《日本药典 XVIII》中,Angelicae acutilobae radix 被定义为当归(Apiaceae)的根,日本长期以来一直以工业规模生产该药。随着农民老龄化和产地人口减少,国内供应量近来有所下降,目前大部分供应量从中国进口。由于用于生产中药干根的繖形花科植物根的形态和化学特征仅略有不同,因此可能会错误地识别粗药繖形花科植物根的植物物种。特别是在中国广泛使用的当归和刺五加,很难通过形态和化学特征进行准确鉴别。因此,为了区分Angelicae acutilobae radix和其他来源于中国药用芹科植物的萝卜,我们建立了DNA标记。利用叶绿体 psbA-trnH 基因间间隔区和核内转录间隔区的 DNA 序列,可以明确地鉴定出当归和包括当归在内的其他中药芹属植物的根。
{"title":"Identification of Angelica acutiloba, A. sinensis, and other Chinese medicinal Apiaceae plants by DNA barcoding","authors":"Motoyasu Minami,&nbsp;Ryusaku Tanaka,&nbsp;Takako Mori,&nbsp;Taichi Fujii,&nbsp;Takashi Tsuchida","doi":"10.1007/s11418-024-01796-0","DOIUrl":"10.1007/s11418-024-01796-0","url":null,"abstract":"<div><p>Crude drug Angelicae acutilobae radix is one of the most important crude drugs in Japanese traditional medicine and is used mainly for the treatment of gynecological disorders. In the listing in the Japanese Pharmacopoeia XVIII, Angelicae acutilobae radix is defined as the root of <i>Angelica acutiloba</i> (Apiaceae), which has long been produced on an industrial scale in Japan. With the aging of farmers and depopulation of production areas, the domestic supply has recently declined and the majority of the supply is now imported from China. Due to having only slightly different morphological and chemical characteristics for the Apiaceae roots used to produce dried roots for Chinese medicines, the plant species originating the crude drug Apiaceae roots may be incorrectly identified. In particular, Angelicae sinensis radix, which is widely used in China, and Angelicae acutilobae radix are difficult to accurately identify by morphology and chemical profiles. Thus, in order to differentiate among Angelicae acutilobae radix and other radixes originated from Chinese medicinal Apiaceae plants, we established DNA markers. Using DNA sequences for the chloroplast <i>psb</i>A–<i>trn</i>H intergenic spacer and nuclear internal transcribed spacer regions, Angelicae acutilobae radix and other Chinese Apiaceae roots, including Angelicae sinensis radix<i>,</i> can be definitively identified.</p></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"792 - 798"},"PeriodicalIF":2.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139995166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments 在低压缺氧环境中,芍药苷可减轻杯状突变并改善急性心肌梗死后的左心室重塑。
IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-01 DOI: 10.1007/s11418-024-01781-7
Xin Fang, Yaoxuan Ji, Shuang Li, Lei Wang, Bo He, Bo li, Boshen Liang, Hongke Yin, Haotian Chen, Duojie Dingda, Bing Wu, Fabao Gao

This study investigates the cardioprotective effects of Paeoniflorin (PF) on left ventricular remodeling following acute myocardial infarction (AMI) under conditions of hypobaric hypoxia. Left ventricular remodeling post-AMI plays a pivotal role in exacerbating heart failure, especially at high altitudes. Using a rat model of AMI, the study aimed to evaluate the cardioprotective potential of PF under hypobaric hypoxia. Ninety male rats were divided into four groups: sham-operated controls under normoxia/hypobaria, an AMI model group, and a PF treatment group. PF was administered for 4 weeks after AMI induction. Left ventricular function was assessed using cardiac magnetic resonance imaging. Biochemical assays of cuproptosis, oxidative stress, apoptosis, inflammation, and fibrosis were performed. Results demonstrated PF significantly improved left ventricular function and remodeling after AMI under hypobaric hypoxia. Mechanistically, PF decreased FDX1/DLAT expression and serum copper while increasing pyruvate. It also attenuated apoptosis, inflammation, and fibrosis by modulating Bcl-2, Bax, NLRP3, and oxidative stress markers. Thus, PF exhibits therapeutic potential for left ventricular remodeling post-AMI at high altitude by inhibiting cuproptosis, inflammation, apoptosis and fibrosis. Further studies are warranted to optimize dosage and duration and elucidate PF’s mechanisms of action.

本研究探讨了在低压缺氧条件下,芍药苷(PF)对急性心肌梗死(AMI)后左心室重塑的心脏保护作用。急性心肌梗死后的左心室重塑在加重心力衰竭方面起着关键作用,尤其是在高海拔地区。该研究利用大鼠急性心肌梗死模型,旨在评估在低压缺氧条件下 PF 的心脏保护潜力。90 只雄性大鼠被分为四组:常氧/低氧条件下的假手术对照组、急性心肌梗死模型组和 PF 治疗组。在诱发急性心肌梗死后给大鼠服用 PF 4 周。使用心脏磁共振成像评估左心室功能。对杯突症、氧化应激、细胞凋亡、炎症和纤维化进行了生化检测。结果表明,在低压缺氧条件下,PF能明显改善急性心肌梗死后的左心室功能和重塑。从机制上讲,PF 降低了 FDX1/DLAT 的表达和血清铜,同时增加了丙酮酸。它还通过调节 Bcl-2、Bax、NLRP3 和氧化应激标记物来减轻细胞凋亡、炎症和纤维化。因此,通过抑制杯突、炎症、细胞凋亡和纤维化,PF 对高海拔地区急性心肌梗死后的左心室重塑具有治疗潜力。还需要进一步研究,以优化剂量和持续时间,并阐明 PF 的作用机制。
{"title":"Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments","authors":"Xin Fang,&nbsp;Yaoxuan Ji,&nbsp;Shuang Li,&nbsp;Lei Wang,&nbsp;Bo He,&nbsp;Bo li,&nbsp;Boshen Liang,&nbsp;Hongke Yin,&nbsp;Haotian Chen,&nbsp;Duojie Dingda,&nbsp;Bing Wu,&nbsp;Fabao Gao","doi":"10.1007/s11418-024-01781-7","DOIUrl":"10.1007/s11418-024-01781-7","url":null,"abstract":"<div><p>This study investigates the cardioprotective effects of Paeoniflorin (PF) on left ventricular remodeling following acute myocardial infarction (AMI) under conditions of hypobaric hypoxia. Left ventricular remodeling post-AMI plays a pivotal role in exacerbating heart failure, especially at high altitudes. Using a rat model of AMI, the study aimed to evaluate the cardioprotective potential of PF under hypobaric hypoxia. Ninety male rats were divided into four groups: sham-operated controls under normoxia/hypobaria, an AMI model group, and a PF treatment group. PF was administered for 4 weeks after AMI induction. Left ventricular function was assessed using cardiac magnetic resonance imaging. Biochemical assays of cuproptosis, oxidative stress, apoptosis, inflammation, and fibrosis were performed. Results demonstrated PF significantly improved left ventricular function and remodeling after AMI under hypobaric hypoxia. Mechanistically, PF decreased FDX1/DLAT expression and serum copper while increasing pyruvate. It also attenuated apoptosis, inflammation, and fibrosis by modulating Bcl-2, Bax, NLRP3, and oxidative stress markers. Thus, PF exhibits therapeutic potential for left ventricular remodeling post-AMI at high altitude by inhibiting cuproptosis, inflammation, apoptosis and fibrosis. Further studies are warranted to optimize dosage and duration and elucidate PF’s mechanisms of action.</p></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"78 3","pages":"664 - 676"},"PeriodicalIF":2.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139995167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Natural Medicines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1